Balkrishnan R, Cayce KA, Kulkarni AS, Orsagh T, Gallagher JR, Richmond D,
Feldman SR. Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatolog Treat 2006;17(3):162-6.
Balkrishnan R, Kulkarni AS, Cayce K, Feldman SR. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis 2006 Apr;77(4):251-5.
Bhosle MJ, Feldman SR, Camacho FT, Timothy Whitmire J, Nahata MC,Balkrishnan R. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis. J Dermatolog Treat 2006;17(5):294-301.
Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006 Jun;6(4):35.
Bivens MM, Bhosle M, Balkrishnan R, Camacho FT, Feldman SR, Fleischer AB Jr. Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data. Dermatol Surg 2006 Dec;32(12):1473-9.
Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R. Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat 2006;17(3):136-42.
Horwitz IB, McCall BP, Feldman SR, Balkrishnan R. Surveillance and assessment of occupational dermatitis using Rhode Island workers’ compensation data 1998 to 2002. J Am Acad Dermato 2006 Aug;55(2):361-3.
Kaplansky DB, Kademian ME, Vancourt RB. Metastatic squamous cell carcinoma resembling cellulitis and osteomyelitis of the fifth toe. J Foot & Ankle Surg 2006 May-June;45(3):182-4.
Kirkland R, Pearce DJ, Balkrishnan R, Feldman SR. Critical factors determining the potency of topical corticosteroids. J Dermatolog Treat 2006;17(3):133-5.
Krejci-Manwaring J, McCarty MA, Camacho F, Carroll CL, Johnson K, Manuel J,
Balkrishnan R, Hartle J, Fleischer A Jr, Feldman SR. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol 2006 May;54(5 Suppl):S235-6.
Kwon S, Campbell L, Zirwas M. Role of protective gloves in the causation and treatment of occupational irritant contact dermatitis. J Amer Acad Dermatol 2006;55(5):891-896.
Pearce DJ, Camacho F, Balkrishnan R, Fleischer AB Jr, Feldman SR. Trends in on and off-label calcipotriene use. J Dermatolog Treat 2006;17(5):308-13.
Pearce DJ, Higgins KB, Stealey KH, Balkrishnan R, Crane MM, Camacho F, Fleischer AB Jr, Feldman SR. Adverse events from systemic therapies for psoriasis are common in clinical practice. J Dermatolog Treat 2006;17(5):288-93.
Pearce DJ, Lucas J, Wood B, Chen J, Balkrishnan R, Feldman SR. Death from psoriasis: representative US data. J Dermatolog Treat 2006;17(5):302-3.
Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB Jr, Feldman SR. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol 2006 Apr;45(4):370-4.
Nelson AA, Miller AD, Fleischer AB, Balkrishnan R, Feldman SR. How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat 2006;17(4):224-8.
Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. New treatments for psoriasis: which biologic is best? J Dermatolog Treat 2006;17(2):96-107.
Simpson JF, Yelverton CB, Balkrishnan R, Fleischer A Jr, Lide W, Feldman SR. Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis. Manag Care Interface 2006 Jun;19(6):39-43.
Tusa MG, Ladd M, Kaur M, Balkrishnan R, Feldman SR. Adapting electronic adherence monitors to standard packages of topical medications. J Am Acad Dermatol 2006 Nov;55(5):886-7.
Warino L, Balkrishnan R, Feldman SR. Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol 2006 Jun;5(6):527-32.
Yelverton CB, Balkrishnan R, Feldman SR. The utility of a data-logging device for measuring adherence to home phototherapy. Photodermatol Photoimmunol Photomed 2006 Oct;22(5):270-2.